Adapthealth CORP Form 4 insider transactions

NASDAQ
Director Bradley J. Coppens reports a transaction involving AdaptHealth Corp. common stock on June 24, 2024, including an acquisition of 17,523 shares and a disposition of 56,000 shares.
NASDAQ
Director Susan Weaver reports acquisition and disposal of AdaptHealth Corp. common stock on June 24, 2024.
NASDAQ
Director Richard Barasch of AdaptHealth Corp. sold 3,559 shares of common stock on June 18, 2024, to cover tax withholding liabilities related to the vesting of a restricted stock grant.
NASDAQ
Peloton Equity GP, LLC distributed 2,027,496 shares of AdaptHealth Corp. common stock to its members on June 11, 2024.
NASDAQ
Director Theodore B. Lundberg reports a distribution of AdaptHealth Corp. common stock by Peloton Equity GP, LLC to its members.
NASDAQ
Suzanne Foster, CEO of AdaptHealth Corp., reports the acquisition of 323,511 restricted stock units convertible to common stock.
NASDAQ
Richard Barasch, Interim CEO of AdaptHealth Corp., reports the disposition of 8,547 shares of common stock to cover tax withholding liabilities.
NASDAQ
Richard Barasch, Interim CEO of AdaptHealth Corp., reports the acquisition of restricted stock units and a previously made gift of common stock.
NASDAQ
AdaptHealth's CFO, Jason Clemens, reported acquiring 128,380 shares of common stock and disposing of shares on March 18, 2024.
NASDAQ
James E. Flynn, along with several Deerfield entities, reported the sale of AdaptHealth Corp. Class A Common Stock between March 8 and March 12, 2024, resulting in a decrease in their beneficial ownership.
NASDAQ
Richard Barasch, Interim CEO of AdaptHealth Corp., reports disposition of shares to cover tax liabilities and acquisition of restricted stock units.